FOOTHILL RANCH, Calif.,
Jan. 5, 2022 /PRNewswire/
-- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental
lasers, today announced it will participate in the H.C. Wainwright
BIOCONNECT Virtual Investor Conference being held on January 10-13, 2022. BIOLASE President and CEO
John Beaver is scheduled to deliver
a formal presentation and host virtual one-on-one meetings with
investors.
Event: H.C. Wainwright BIOCONNECT Virtual Investor
Conference
Date: January 10-13, 2022
Pre-recorded Investor Presentation Webcast (available
January 10, 2022 at 7 am ET):
https://journey.ct.events/view/b5b9fa4b-49a2-4a21-9919-1a0d96ad7402
One-on-One Investor Meetings: Available on Thursday, January 13, 2022
To schedule a one-on-one investor meeting with BIOLASE
management, please contact BIOLASE's investor relations firm, EVC
Group, LLC at tkehrli@evcgroup.com.
About BIOLASE, Inc.
BIOLASE is a medical device company that develops,
manufactures, markets, and sells laser systems in dentistry and
medicine. BIOLASE's products advance the practice of dentistry and
medicine for patients and healthcare professionals. BIOLASE's
proprietary laser products incorporate approximately 271 patented
and 40 patent-pending technologies designed to provide biologically
and clinically superior performance with less pain and faster
recovery times. BIOLASE's innovative products provide cutting-edge
technology at competitive prices to deliver superior results for
dentists and patients. BIOLASE's principal products are
revolutionary dental laser systems that perform a broad range of
dental procedures, including cosmetic and complex surgical
applications. BIOLASE has sold over 41,200 laser systems
to date in over 80 countries around the world. Laser products under
development address BIOLASE's core dental market and other adjacent
medical and consumer applications.
For updates and information
on Waterlase iPlus®, Waterlase Express™, and
laser dentistry, find BIOLASE online
at www.biolase.com, Facebook at www.facebook.com/biolase,
Twitter at www.twitter.com/biolaseinc, Instagram
at www.instagram.com/waterlase_laserdentistry, and LinkedIn
at www.linkedin.com/company/biolase.
BIOLASE®,
Waterlase® and Waterlase iPlus® are
registered trademarks of BIOLASE, Inc.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/biolase-to-present-at-the-hc-wainwright-bioconnect-virtual-investor-conference-301454324.html
SOURCE BIOLASE, Inc.